p53 immunostaining pattern in Brazilian patients with hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is an important type of cancer etiologically related to some viruses, chemical carcinogens and other host or environmental factors associated to chronic liver injury in humans. The tumor suppressor gene p53 is mutated in highly variable levels (0-52%) of HCC in different countries. OBJECTIVE: The objective of the present study was to compare the frequency of aberrant immunohistochemical expression of p53 in HCC occurring in cirrhotic or in non-cirrhotic patients as well as in liver cell dysplasia and in adenomatous hyperplasia. We studied 84 patients with HCC or cirrhosis. RESULTS: We detected p53 altered immuno-expression in 58.3% of patients in Grade III-IV contrasting to 22.2% of patients in Grade I-II (p = 0.02). Nontumorous areas either in the vicinity of HCC or in the 30 purely cirrhotic cases showed no nuclear p53 altered expression, even in foci of dysplasia or adenomatous hyperplasia. No significant difference was found among cases related to HBV, HCV or alcohol. CONCLUSION: The high frequency of p53 immunoexpression in this population is closer to those reported in China and Africa, demanding further studies to explain the differences with European and North American reports.

Metástases Cardíacas de Tumor do Cólon

O diagnóstico de metástases cardíacas pré-mortem é raro. Apresenta-se um caso de metástases cardíacas de adenocarcinoma do cólon - massa intracavitária na aurícula direita e massa vegetante na válvula tricúspide - as quais foram diagnosticadas por ecocardiografia transtorácica bidimensional. As autoras fazem uma breve referência aos aspectos clínicos e imagiológicos dos tumores cardíacos secundários, com especial ênfase para a ecocardiografia.

Complexos de escorpionato: papel biológico como potenciais agentes anti-tumor

Dissertação para obtenção do Grau de Mestre em Genética Molecular e Biomedicina

Manifestações Sistémicas de um Tumor Cardíaco

Os autores apresentam um caso clínico de mixoma cardíaco que se manifestou por dois episódios de acidentes vasculares cerebrais (AVC) e mimetizou um processo de vasculite. Tecem considerações sobre a complexidade e gravidade desta patologia, o seu diagnóstico diferencial, terapêutica e prognóstico.

Tumor Fibroso Localizado Maligno da Pleura

Os autores apresentam um caso de tumor fibroso localizado na pleura, maligno, com dimensões gigantes: 26x14x12 cm e P=1,25 Kg, de um doente de sexo feminino de 56 anos. O tumor ocupava praticamente os 2/3 inferiores do campo pulmonar direito com uma inserção invulgar na pleura parietal diafragmática não pediculado e com características histológicas malignas. O diagnóstico de tumor fibroso localizado na pleura, foi feito no material obtido por punção aspirativa por agulha fina. O estudo imunocitoquímico realizado posteriormente na peça operatória confirmou o diagnóstico feito na citologia aspirativa. A avaliação da malignidade só foi feita no exame histológico da peça operatória, utilizando os critérios histológicos de alta celularidade, pleomorfismo celular, actividade mitótica (mais de quatro mitoses em dez campos de grande ampliação do microscópio), áreas de hemorragia e de necrose.

Primary liver AIDS-related lympoma

Non-Hodgkin's lymphomas (NHL) are the second most frequent malignancies in AIDS patients. The majority of NHL associated with AIDS involves extranodal sites, especially the digestive tract and the central nervous system. Primary liver lymphoma (PLL) is an uncommon neoplasm among these patients. Ultrasonography and computed tomography scans may be helpful in the diagnosis of focal hepatic lymphoma. Image-guided fine-needle biopsy with histopathology of the liver lesions is the gold standard for the diagnosis of hepatic lymphoma. We report a case of PLL as the initial manifestation of AIDS in a patient without any previous infection by hepatitis C or B virus, presented as multiple and large hepatic masses.

Predictive Variables Affecting Transfusion Requirements in Orthotopic Liver Transplantation

INTRODUCTION AND AIMS: Adult orthotopic liver transplantation (OLT) is associated with considerable blood product requirements. The aim of this study was to assess the ability of preoperative information to predict intraoperative red blood cell (RBC) transfusion requirements among adult liver recipients. METHODS: Preoperative variables with previously demonstrated relationships to intraoperative RBC transfusion were identified from the literature: sex, age, pathology, prothrombin time (PT), factor V, hemoglobin (Hb), and platelet count (plt). These variables were then retrospectively collected from 758 consecutive adult patients undergoing OLT from 1997 to 2007. Relationships between these variables and intraoperative blood transfusion requirements were examined by both univariate analysis and multiple linear regression analysis. RESULTS: Univariate analysis confirmed significant associations between RBC transfusion and PT, factor V, Hb, Plt, pathology, and age (P values all < .001). However, stepwise backward multivariate analysis excluded variables Plt and factor V from the multiple regression linear model. The variables included in the final predictive model were PT, Hb, age, and pathology. Patients suffering from liver carcinoma required more blood products than those suffering from other pathologies. Yet, the overall predictive power of the final model was limited (R(2) = .308; adjusted R(2) = .30). CONCLUSION: Preoperative variables have limited predictive power for intraoperative RBC transfusion requirements even when significant statistical associations exist, identifying only a small portion of the observed total transfusion variability. Preoperative PT, Hb, age, and liver pathology seem to be the most significant predictive factors but other factors like severity of liver disease, surgical technique, medical experience in liver transplantation, and other noncontrollable human variables may play important roles to determine the final transfusion requirements.

Histerectomia e Tumor Uterino: Estudo Comparativo entre Via Vaginal e Abdominal

Objectivos: Determinar a eficiência e segurança da via vaginal na patologia uterina benigna na ausência de prolapso e de contra-indicações absolutas. Material e métodos: Os autores efectuaram uma revisão das histerectomias vaginais (HV) efectuadas na ausência de prolapso urogenital (n=29). Como grupo controle foi estudado o mesmo número de histerectomias abdominais (HÁ). Resultados: Em n=29 houve 20,7% de complicações perioperatórias e pós-operatórias (via vaginal), e no grupo controle 65,5% (via abdominal). Conclusão: A via vaginal tem menor morbilidade e é mais eficiente em termos de custo operacional e benefício.

Leiomioma Intramural da Bexiga em Doente com Tumor Fibroso Pélvico - Caso Clínico

Introdução: O leiomioma vesical é um tumor benigno raro que representa,aproximadamente, 0,5% do total de neoplasias da bexiga. É frequentemente um achado imagiológico, sendo a sua localização e dimensões determinantes no desenvolvimento de sintomatologia e no tipo de procedimento a efectuar. Caso Clínico: Reporta-se o caso de um doente com queixas urinárias de disúria, polaquiúria e esforço miccional, inicialmente interpretadas como HBP. A investigação diagnóstica culminou com a enucleação de uma volumosa massa intramural da bexiga, com diagnóstico histológico de leiomioma, num doente com antecedentes de doença de Madelung e excisão prévia de um tumor fibroso paravesical. Discussão: O leiomioma vesical, embora apresentando características imagiológicas típicas, deve ser sempre biopsado para confirmação histológica da sua etiologia. O tumor fibroso pélvico apresenta sempre indicação cirúrgica pois, numa minoria de casos, pode apresentar comportamento agressivo com infiltração dos órgãos adjacentes.

Papel da Linfadenectomia no Tumor Renal

Objetivos: Avaliar os benefícios e morbilidade da linfadenectomia (LND) como componente integral da nefrectomia radical. Material e Métodos: Efetuámos uma pesquisa bibliográfica exaustiva com recurso a vários motores de busca informática, incluindo MEDLINE, PUBMED, GOOGLE SEARCH e AUA MEDSEARCH, correspondendo o período de análise aos últimos 30 anos, entre 1980 e 2010, e utilizando como palavras-chave, exclusivamente em terminologia anglosaxónica, as seguintes: lymph node dissection, lymphadenectomy, renal cell carcinoma, renal tumor, kidneyneoplasms, radical nephrectomy, staging e prognosis. Para uma validação rigorosa das publicações relevantes, utilizámos a Tabela de Níveis de Evidência e Graus de Recomendação de Oxford publicada em Março de 2009. Com base nestas informações, tentámos analisar em detalhe o papel da linfadenectomia no tratamento do carcinoma de células renais e o seu impacto em termos prognósticos. Resultados: Em mais de 150 artigos, considerados pelos autores como relevantes e bem estruturados, apenas 1 era um estudo prospetivo e aleatorizado (Nível de Evidência 1/Grau de Recomendação A). Neste estudo de 772 doentes N0 M0, a taxa de LND positiva foi de 4,0% em status ganglionar clinicamente negativo, não tendo havido qualquer vantagem na sobrevivência e, por isso, não foi recomendada por rotina. Embora a informação obtida da maioria dos estudos seja contraditória, vários estudos retrospetivos recomendam a LND como potencialmente benéfica em casos selecionados de tumor agressivo e em contexto de nefrectomia citorredutora seguida de terapêutica adjuvante,realçando alguns autores a remoção total, sempre que possível, de quaisquer adenopatias palpáveis. Conclusão: A LND não está recomendada, por rotina, em tumores renais com gânglios linfáticos clinicamente negativos. Terá algum benefício potencial em casos selecionados de tumor agressivo e em contexto de cirurgia citorredutora seguida de terapêutica adjuvante, incentivando-se nestas situações a remoção total, se possível, das adenopatias palpáveis. Consequentemente, o tipo de LND deverá ser individualizada e dependente do estadio/extensão da doença neoplásica. Será, provavelmente, útil em futuros protocolos de terapêutica adjuvante desde que associados a inquestionável melhoria da sobrevivência.

Dermoid Tumor of the Lateral Wall of the Cavernous Sinus

BACKGROUND: Congenital intracranial dermoid tumors are very rare. The location of these dermoid lesions in the cavernous sinus and the complexity of the operative procedure for these lesions have been noted by several authors. Dermoid tumors originating in the cavernous sinus are usually interdural, and thus blurred vision is an uncommon presentation. CASE DESCRIPTION: Herein we report the first incidental case of a cavernous sinus dermoid cyst in a 21-year-old woman. CONCLUSIONS: A literature review was done and the possible treatments and approaches for this lesion are discussed. We consider that surgical treatment is indicated in most incidental cavernous sinus dermoid lesions due to the possible symptoms related to compression or rupture leading to chemical meningitis.

Intraorbital Abducens Nerve Schwannoma

BACKGROUND: Schwannomas of the abducens nerve are extremely rare tumors. The tumor may be located within the cavernous sinus or more often at the prepontine region. However, literature research has identified only one case of isolated schwannoma of the orbit, arising from the terminal branches of the abducens nerve to the lateral rectus muscle. This is only the second report of an abducens nerve schwannoma located entirely intraconal. CASE DESCRIPTION: We report a case of an intraorbital abducens nerve schwannoma in a 42-year-old man with no signs of neurofibromatosis. The lesion resulted in progressive diplopia and focal abducens palsy. The clinical, radiologic, and pathologic features are presented. RESULTS: We point the particular aspects and discuss the possible treatments and approaches to preserve nerve function. CONCLUSIONS: Being a benign lesion, one of the goals has always been total removal. The knowledge of the correct anatomic features made us believe that the VI nerve function could be preserved. Our case is the first example of a total removal with eye abduction preserved. Because of that, we believe that it is reasonable to aim for these goals in future cases.

Prostatic Artery Embolization in the Treatment of Benign Prostatic Hyperplasia: Short and Medium Follow-Up

To evaluate the short and mid-term results of prostatic artery embolization in patients with benign prostatic embolization. Retrospective study between March 2009 and June 2011 with 103 patients (mean age 66.8 years, 50-85) that met our inclusion criteria with symptomatic benign prostatic hyperplasia. The clinical outcome was evaluated by the International Prostate Symptom Score (IPSS), quality of life (QoL), International Index of Erectile Function, prostate volume (PV), prostate-specific antigen (PSA), peak urinary flow (Q(max)), and post-void residual volume (PVR) measurements at 3 and 6 months, 1 year, 18 months, and 2 years after PAE and comparison with baseline values was made. Technical and clinical successes, as well as poor clinical outcome definitions, were previously defined. In this review, we evaluate the short and mid-term clinical outcomes and morbidity of patients treated only with non-spherical polyvinyl alcohol. Six months after the procedure, the PV decreased about 23%, IPSS changed to a mean value of 11.95 (almost 50% reduction), the QoL improved slightly more than 2 points, the Q(max) changed to a mean value of 12.63mL/s, the PVR underwent a change of almost half of the baseline value, and the PSA decreased about 2.3ng/mL. In the mid-term follow-up and comparing to the baseline values, we still assisted to a reduction in PV, IPSS, QoL, PVR, and PSA, and an increase in Q(max). Prostatic Artery Embolization is a safe procedure with low morbidity that shows good short- and mid-term clinical outcome in our institution.

Impact of RIFLE Classification in Liver Transplantation

Acute renal failure (ARF) is common after orthotopic liver transplantation (OLT). The aim of this study was to evaluate the prognostic value of RIFLE classification in the development of CKD, hemodialysis requirement, and mortality. Patients were categorized as risk (R), injury (I) or failure (F) according to renal function at day 1, 7 and 21. Final renal function was classified according to K/DIGO guidelines. We studied 708 OLT recipients, transplanted between September 1992 and March 2007; mean age 44 +/- 12.6 yr, mean follow-up 3.6 yr (28.8% > or = 5 yr). Renal dysfunction before OLT was known in 21.6%. According to the RIFLE classification, ARF occurred in 33.2%: 16.8% were R class, 8.5% I class and 7.9% F class. CKD developed in 45.6%, with stages 4 or 5d in 11.3%. Mortality for R, I and F classes were, respectively, 10.9%, 13.3% and 39.3%. Severity of ARF correlated with development of CKD: stage 3 was associated with all classes of ARF, stages 4 and 5d only with severe ARF. Hemodialysis requirement (23%) and mortality were only correlated with the most severe form of ARF (F class). In conclusion, RIFLE classification is a useful tool to stratify the severity of early ARF providing a prognostic indicator for the risk of CKD occurrence and death.